{
  "title": "REPRISED -- Treating SCD before it hurts",
  "itunes:season": 2,
  "itunes:title": "REPRISED -- Treating SCD before it hurts",
  "itunes:episodeType": "full",
  "guid": "538acc97-d8e0-4f0d-a5e5-b8db14ee813f",
  "link": "https://share.transistor.fm/s/8938415a",
  "description": "In this episode, first released in the fall of 2021, Daniel sits down with Dr. Patrick Hines, the founder and CEO at Functional Fluidics and the leading Sickle Cell Disease (SCD) researcher at Wayne State University in Detroit, where he set up a transformational study on defining the health of red blood cells. Dr. Hines also introduces us to exciting new therapies — recently approved — and the importance of being proactive with SCD.",
  "pubDate": "Thu, 29 Sep 2022 13:43:44 -0400",
  "author": "CVS Health",
  "enclosure": "",
  "itunes:author": "CVS Health",
  "itunes:image": "",
  "itunes:duration": 1226,
  "itunes:summary": "In this episode, first released in the fall of 2021, Daniel sits down with Dr. Patrick Hines, the founder and CEO at Functional Fluidics and the leading Sickle Cell Disease (SCD) researcher at Wayne State University in Detroit, where he set up a transformational study on defining the health of red blood cells. Dr. Hines also introduces us to exciting new therapies — recently approved — and the importance of being proactive with SCD.",
  "itunes:subtitle": "In this episode, first released in the fall of 2021, Daniel sits down with Dr. Patrick Hines, the founder and CEO at Functional Fluidics and the leading Sickle Cell Disease (SCD) researcher at Wayne State University in Detroit, where he set up a transform",
  "itunes:keywords": 403121,
  "itunes:explicit": "No"
}